Compounds > bromodeoxyuridine
Page last updated: 2024-08-17

bromodeoxyuridine and n(6)-cyclopentyladenosine

bromodeoxyuridine has been researched along with n(6)-cyclopentyladenosine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J1
Burris, D; Nielsen, TB; Rhee, P; Sun, LL; Xu, LL1
Rivkees, SA; Zhao, Z1

Other Studies

3 other study(ies) available for bromodeoxyuridine and n(6)-cyclopentyladenosine

ArticleYear
Chemical genetics reveals a complex functional ground state of neural stem cells.
    Nature chemical biology, 2007, Volume: 3, Issue:5

    Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells

2007
Cyclopentyladenosine improves cell proliferation, wound healing, and hair growth.
    The Journal of surgical research, 1999, Volume: 87, Issue:1

    Topics: 3T3 Cells; Adenosine; Animals; Bromodeoxyuridine; Cell Division; Female; Hair Follicle; Mice; Mice, Inbred C57BL; Wound Healing

1999
Inhibition of cell proliferation in the embryonic myocardium by A1 adenosine receptor activation.
    Developmental dynamics : an official publication of the American Association of Anatomists, 2001, Volume: 221, Issue:2

    Topics: Adenosine; Apoptosis; Bromodeoxyuridine; Cell Differentiation; Cell Division; Cells, Cultured; Heart; In Situ Hybridization; In Situ Nick-End Labeling; Myocardium; Organ Culture Techniques; Receptors, Purinergic P1; Time Factors

2001